CJC-1295 (without DAC) and Pancragen Interaction

Monitor
Mechanism-based 47% confidence

CJC-1295 (without DAC) and Pancragen have an interaction requiring monitoring for interaction with 47% confidence. Both CJC-1295 (without DAC) and Pancragen affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Pancragen

KEDW Tetrapeptide | Pancreas Bioregulator

Pancragen works through epigenetic regulation by interacting with chromatin complexes and DNA structures to modulate pancreatic gene expression. Research shows it upregulates critical transcription factors for pancreatic cell maturation including Pdx1, Pax6, Ptf1a, Foxa2, Nkx2.

Half-life: Not established Typical dose: 10-20mg daily longevity, metabolic
insulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (CJC-1295 (without DAC), Pancragen). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), Pancragen). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Pancragen?

Yes, but with caution. Both CJC-1295 (without DAC) and Pancragen affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is CJC-1295 (without DAC) and Pancragen safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Pancragen?

Both CJC-1295 (without DAC) and Pancragen affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Pancragen?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Pancragen has a half-life of Not established. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Pancragen

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.